Neurological diseases
Neurological diseases encompass a wide range of conditions affecting the brain, spinal cord, and nervous system. These include well-known neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, as well as other neurological disorders that affect patients’ daily lives and long-term health. Due to ageing populations and increasing disease complexity, neurological diseases are a growing health challenge in Luxembourg and throughout the world.


At the Luxembourg Research Clinic (LRC), clinicians, researchers and healthcare professionals work closely together to improve the understanding, diagnosis and treatment of neurological conditions. The goal is to support earlier diagnosis, more personalised care and better outcomes for patients. The various programmes and studies give patients access to advanced clinical studies, supported by expertise in diagnostics, imaging, and care.
Diseases we study:
- Parkinson’s disease and atypical parkinsonisms
- Alzheimer’s disease and other dementias
- Multiple Sclerosis
- Brain cancer & metastasis
“
Today, by bringing research and patient care closer together, we can detect neurological diseases earlier and develop more effective treatments that make a real difference to people’s lives”
Prof. Dr Rejko Krüger, Coordinator of the National Centre of Excellence for Research on Parkinson’s disease (NCER-PD)
Coordinator

Institutional contact points

Related programmes
ParkinsonNet Luxembourg
Parkinson’s disease affects many aspects of daily life and can cause a wide range of symptoms that differ from one person to another. As a…
pdp
The Programme Dementia Prevention (pdp) is a national initiative supporting people who are experiencing mild changes in their memory or thinking, such as Subjective Cognitive…
NCER-PD
The National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD) is a long-term research programme dedicated to improving the understanding, diagnosis, and treatment of…
Related studies
Lets’Telerehab
The Lets’Telerehab study aims to evaluate a new home-based cardiac rehabilitation programme delivered through secure video consultations.
IMPRESS
The IMPRESS study aims to better understand why some people with non-small cell lung cancer (NSCLC) or triple-negative breast cancer (TNBC) respond to immunotherapy before…
ImMI-Tx
The ImMI-Tx project aims to better understand the role of the gut microbiome – the community of microorganisms living naturally in the digestive tract -…
Related news
Small country, significant capacity
Luxembourg may be one of Europe’s smallest countries, but the Luxembourg Research Clinic demonstrates how its highly connected national network…
Clinnova Consortium Agreement signed, marking a major milestone for health research across Europe
Thanks to a joint investment from LIH and the Ministry of Health, the national biobank accessible to LRC studies has…
Building on Luxembourg’s Research Strengths
The Luxembourg Research Clinic brings together the strengths of Luxembourg’s leading healthcare, research and academic institutions, building on established expertise…
Upcoming events
Clinical Research Luxembourg Conference
Why does clinical research matter today in Luxembourg? Clinical research plays a vital role in improving patient care, driving medical…



